The global caspofungin market is expected to grow at a significant CAGR of around 5% during the forecast years. Caspofungin is an anti-fungal drug used for the treatment of patients suffering invasive candidiasis, invasive aspergillosis, and suspected fungal infections. Caspofungin is significantly facing increasing demand due to patients who cannot use or do not respond to other antifungal drugs such as itraconazole and amphotericin B. In addition, it can also be used with the combination of other antifungal drugs such as voriconazole for more effective results. According to clivelandclinic.org, it has been reported that there is a small amount of candida fungus present in most people’s mouths, skin, and digestive tracts. This fungus can grow in more numbers due to illness, stress, or medications which disturbs the balance that further requires caspofungin drugs. Furthermore, the people’s inclination towards generic drugs to cut down on their healthcare costs in developing countries has also increased the development of generic forms of caspofungin drugs including “Cancidas”. 

Segmental Outlook

The global caspofungin market is segmented based on infection type and dosage form. Based on Infection type, the market is sub-segmented into candidiasis and thrush. Based on the Dosage form, the market is sub-segmented into powder, ointment, and drugs. Among these, the thrush infection type of caspofungin market is expected to hold prominent shares in the global caspofungin market.

Global Caspofungin Market by Dosage Form, 2021(%) 

The Ointment Segment is Anticipated to Hold a Major Share in the Global Caspofungin market.

The ointment segment is anticipated to hold the major share in the global caspofungin market due to increasing patients of bacterial infections across the globe. An ointment is the easiest form of application of caspofungin drugs which is applied on the infected body areas. The ointment form of the chemical is a very stable form and can be absorbed very quickly. In addition, the ointment dosage form is an alternative for patients who face difficulty in taking the oral dosage form. Moreover, the caspofungin ointment is directly applied to infected body parts causing no effect on the liver as they directly come in contact with the infected area. 

Regional Outlooks

The global caspofungin market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The North American caspofungin market is expected to hold the major share of the global caspofungin market due to the increased number of patients suffering from fungal infections including fungemia candidiasis. In addition, the increasing patients of fungal infection in aged people is also expected to be the reason for the major share in North America. According to Center for Disease Control and Prevention (CDC), it has been reported that the most common cause of bloodstream infection in people aged over 60 is candida.

Global Caspofungin Market Growth by Region, 2022-2028 

The Asia-Pacific Region is Expected to Grow at a Significant CAGR among the Global Caspofungin Market During Forecast Year.

The Asia-Pacific region is anticipated to grow at a significant CAGR during the forecast year due to increasing number of patients of fungal infection across the region. In addition, the increasing population of aged people in the Asia Pacific region has also developed the increasing risk of fungal diseases. Resulting in increased demand for caspofungin drugs. According to World Health Org. (WHO), it has been reported that the highest number of aged populations is present in China and Japan in the Asia Pacific region. The key market players in the region are investing in R&D activities due to the high prevalence of fungal diseases and the problem associated with their treatment. As a result, new antifungal medications are being developed to achieve better results, aiding in market growth. ?

Market Players Outlook

The major companies serving the global caspofungin market include Athenex Inc., Merck and Co. Inc., Fresenius SE & Co. KGaA, Xellia Pharmaceuticals ApS, Sun Pharmaceutical Industries Ltd., and Many others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches. For instance, In August 2021, Xellia Pharmaceuticals ApS started operating their manufacturing facility commercially in Cleveland, Ohio and released the first drug from the manufacturing site for distribution in hospitals across the US. The first drug to be released from the manufacturing site was anti-infective.

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global caspofungin market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market